Translational Development...

NASDAQ: TDAC · Real-Time Price · USD
10.32
0.00 (0.00%)
At close: Aug 15, 2025, 10:41 AM
10.32
0.00%
After-hours: Aug 15, 2025, 04:00 PM EDT

Translational Development Acquisition Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q2 2022
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 May 31, 2022
Net Income
1.48M -8.04K -61.28K -843 -843 -483.85K -500 -602 -602 -1.7K
Depreciation & Amortization
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
n/a -680.65K 20.8K 22.00 22.00 1.51K 500.00 500.00 500.00 n/a
Other Non-Cash Items
n/a -122.27K -0.00 821.00 821.00 482.34K n/a n/a n/a 1.7K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a -680.65K 20.8K 22.00 22.00 1.51K 500.00 500.00 500.00 n/a
Operating Cash Flow
-231.57K -810.96K -40.48K n/a n/a n/a n/a -102 -102 n/a
Capital Expenditures
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a -174.22M n/a n/a n/a n/a n/a n/a n/a n/a
Investing Cash Flow
n/a -174.22M n/a n/a n/a n/a n/a n/a n/a n/a
Debt Repayment
n/a -663.46K 200K n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
-1.83M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 6.86M -7.5K 35K 35K n/a n/a n/a n/a 62.5K
Financial Cash Flow
n/a 175.25M 192.5K 35K 35K n/a n/a n/a n/a 62.5K
Net Cash Flow
-231.57K 214.14K 152.02K n/a n/a n/a n/a 2.2K n/a 62.5K
Free Cash Flow
-231.57K -810.96K -40.48K n/a n/a n/a n/a -102 -102 n/a